Clinical Trials in North Carolina

Showing 17561-17580 of 20,428 trials

Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome

NCT00583128

The objective of this study is to evaluate the safety and effectiveness of the experimental drug AST-120 in treating patients with non-constipating IBS. The study will test whether or not patients receiving AST-120 experience at least a 50% reduction in the number of days with abdominal pain compared to placebo.

Irritable Bowel Syndrome

Ocera Therapeutics117 participantsStarted Aug 2007

Huntsville, Alabama, United States • Sacramento, California, United States • San Diego, California, United States +14 more locations

TERMINATEDPhase 341 miles

A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).

NCT00441558

To determine if long-term treatment with Flibanserin is safe and to monitor the effectiveness of Flibanserin in Women with HSDD that have already completed a previous study (511.70/71/.74/.75/.105) with Flibanserin.

Sexual Dysfunctions, Psychological

Sprout Pharmaceuticals, Inc1,723 participantsStarted Feb 2007

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +193 more locations

Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome

A One-year Safety Study of Flibanserin to Treat Pre-Menopausal Women With Hypoactive Sexual Desire Disorder (HSDD).

Find Trials by Condition in North Carolina

Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)

Female Upper Genital Tract in HIV-infected Women

Enhancing the Prospective Prediction of Psychosis

Magnetic Seizure Therapy (MST) for the Treatment of Major Depression

Patient Registry Study of Berinert® in Normal Clinical Practice

Clinical Trial in Females for Female Pattern Hair Loss

Dapagliflozin DPPIV Inhibitor add-on Study

Efficacy and Safety Study With Empagliflozin (BI 10773) vs. Placebo as add-on to Metformin or Metformin Plus Sulfonylurea Over 24 Weeks in Patients With Type 2 Diabetes

AST-120 Used to Treat Mild Hepatic Encephalopathy

Lurasidone HCl: A Phase 3 Study of Patients With Acute Schizophrenia

Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label Extension

Effectiveness and Safety Study for JNJ-18054478 in Asthma Patients.

Testosterone Replacement in Men With Non-Metastatic Castrate Resistant Prostate Cancer

Biomarkers of Cockroach Sublingual Immunotherapy 2

A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma

Effects of School Gardens on Children's Diet, Nutritional Knowledge, Etc.

Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD).

Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis